| Literature DB >> 32426699 |
Raymond Fong1,2, Elizabeth C Ward1,3, Anna F Rumbach1.
Abstract
OBJECTIVE: Nasopharyngeal cancer (NPC) has distinct characteristics regarding its global prevalence, initial presentation, management and patient outcomes compared to other subtypes of head and neck cancer (HNC). The mainstay of NPC treatment is chemo-radiation (C/RT) and while dysphagia is a known early and late toxicity of C/RT treatment, the nature of dysphagia post NPC treatment has had limited investigation. The objective of this review is to summarise the existing evidence regarding dysphagia following NPC to inform the future research agenda for this population. Dysphagia incidence, characteristic deficits observed across the phases of swallowing, efficacy of current dysphagia interventions, and effect on quality of life will be explored. DATA SOURCES: Databases including MEDLINE, CINAHL, Embase, Scopus and Web of Science were included.Entities:
Keywords: Deglutition; Dysphagia; Nasopharyngeal carcinoma; Scoping review; Swallowing
Year: 2020 PMID: 32426699 PMCID: PMC7221212 DOI: 10.1016/j.wjorl.2020.02.005
Source DB: PubMed Journal: World J Otorhinolaryngol Head Neck Surg ISSN: 2095-8811
Fig. 1PRISMA flow diagram of search strategy and selection criteria.
Summary of articles detailing prevalence and/or characteristics of dysphagia post NPC.
| Author | Sample size (gender) | Age (years, Mean ± SD) | Tumour staging of participants | Treatment techniques ( | Main objectives | Outcome measures | Main findings | MMAT quality rating |
|---|---|---|---|---|---|---|---|---|
| Chang et al | 12 (1F:11M) and 12 age-matched controls | 45.42 | Stage Ⅱ – 1; | RT (12); Induction chemotherapy (10); Concurrent chemotherapy (11) | Evaluate the effects of RT on tongue function | IOPI | No difference of tongue function compared with normal pre- and post-RT; decreases in tongue function may not start until 2 months post-RT | 4/5 |
| Chang et al | 184 (47F:137M) | 48.3 ± 11.6 | Stage Ⅰ – 24; | 60Co (46); Linear accelerator (138); Neoadjuvant chemotherapy (23);Combination of radiosensitizer (45) | Evaluate swallowing status and the factors influencing swallowing | VFSS and interview of participants for clinical symptoms | Swallowing abnormalities were noted in both acute and chronic groups. Swallowing function continues to deteriorate over time, even many years after RT | 5/5 |
| Chang et al | 76 (19F:57M) | 47.9 ± 10.7 | Stage Ⅰ – 4; | 2D RT (68); 3D-RT (8); Induction chemotherapy (55); Concurrent chemotherapy (65) | Evaluate over a 2-year period the serial swallowing function NPC patients post-RT | VFSS and purpose-built questionnaire rating clinical swallowing performance | At 2 years, patients had a progressively increasing pharyngeal transit time. Dysphagia symptoms subjectively identified decreased after the first month post RT | 4/5 |
| Cheng et al | 40 (9F:31M) | 53.9 | Stage Ⅰ – 9; | 2D-RT (18); IMRT (22); Chemotherapy (20) | Assess the relationship between suprahyoid muscle contraction, hyoid bone displacement, and penetration-aspiration status | Ultrasound and VFSS | Anterior hyoid displacement and pharyngeal constriction ratio were significantly associated with penetration-aspiration | 4/5 |
| Fong et al | 134 (43F:91M) | 63.0 ± 11 | T1-T2 – 48, | Chemotherapy (90) | Investigate the prevalence and associated factors of cervical esophageal clearance issues | VFSS | Esophageal clearance issues are highly prevalent and may co-exist with more severe oral/pharyngeal deficits | 4/5 |
| Hughes et al | 50 (11F:39M) | 49 | Not available | RT only (50) | Investigate the prevalence of long-term dysphagia in patients treated forNPC | Questionnaire, Clinical assessment, VFSS | Both Subjective and objective swallowing abnormalities are common after RT for NPC | 4/5 |
| Ku et al | 100 (32F:68M) | 58 | Stage Ⅰ – 8; | RT only (100) | Investigate the laryngopharyngeal sensory deficits and aspiration | FEESST | Impaired pharyngeal contraction are more significantly related to aspiration than laryngopharyngeal sensory deficits | 4/5 |
| Ku et al | 20 (6F:14M) | 43.9 | Stage Ⅰ-Ⅱ – 9; | RT (20); Boost dose for parapharyngeal extension (17); Concurrent chemotherapy (11) | Study the incidence and the degree of swallowing dysfunction in patients with NPC after RT | Self-rated questionnaire; VFSS | Swallowing problems persisted after 12 months of RT, predominantly having problems with pharyngeal stasis | 3/5 |
| Ng et al | 85 (23F:63M) | 56.8 ± 10.9 | Not available | Not available | Establish silent aspiration occurrence, safe bolus consistency, and their relationship with swallowing physiology in NPC patients post-RT | FEES | Silent aspiration of thin fluids is a common occurrence in dysphagic NPC post-RT, with least aspiration noted on soft diet | 5/5 |
| Patterson et al | 18 (4F:14M) | 52.5 ± 13.06 | T1-T2 – 11, | RT only (5); Concurrent C/RT (13); Neoadjuvant chemotherapy (2) | Evaluate swallowing function in NPC patients with IMRT done | FEES and clinical assessment | Characterised by bolus residue and delay, but no aspiration. Dysphagia was of mild or moderate severity on all measures | 2/5 |
| Phua et al | 18 (7F:11M) | 57.3 ± 8.1 | Not available | RT only (18) | Examine the effects of RT on dysphagia and dysphagia rehabilitation | Clinical assessment and VFSS | Non-oral feeding was needed in over half of the participants and following intervention, half of them could resume oral feeding | 2/5 |
| Wang et al | 33 (8F:25M) and 10 controls | 55.5 ± 8.8 | Stage Ⅰ – 3; | RT only (33) | Quantitatively assess the movement of the hyoid bone and pyriform sinus stasis | VFSS | NPC patients experienced a reduction in hyoid bone displacement, occurring in a forward direction. The displacement of the hyoid bone was less in the aspiration subjects than in those without aspiration | 4/5 |
| Xiong et al | 217 (55F:162M) | 56 | Stage Ⅰ – 22; | RT only (84); C/RT (133) | Identify patients with NPC at risk of developing SRCIs | Retrospective chart review | Swallowing-related chest infection is common in NPC patients. Advanced age, C/RT and recurrent cancer were strong risk factors for NPC patients with RT done to develop SRCIs | 4/5 |
| Yen et al | 3818 (970F:2844M) | 49.2 ± 12.4 | Not available | RT only (533); C/RT (3,281); Single RT (3,285), 2nd course of RT (529) | Assess the incidence of late-onset pneumonia | Retrospective chart review | Late-onset pneumonia is not uncommon in patients with NPC after radiotherapy | 4/5 |
NPC: nasopharyngeal cancer; MMAT: Mixed Methods Appraisal Tool; RT: radiation therapy; IOPI: Iowa Oral Performance Instrument; VFSS: videofluoroscopic swallowing study; IMRT: Intensity modulated radiation therapy; FEES: fiberoptic endoscopic evaluation of swallowing; C/RT: chemo-radiation therapy; QoL: quality of life; SRCIs: swallowing-related chest infections.
Summary of articles investigating the prevention and treatment of dysphagia post NPC.
| Author | Sample size (gender) | Age (years, Mean ± SD) | Tumour staging of participants | Treatment techniques ( | Main objectives | Outcome measures | Main findings | MMAT quality rating |
|---|---|---|---|---|---|---|---|---|
| Cetin et al | 20 (5F:15M) | 3D conformal – 43.1; IMRT – 43.8 | Stage Ⅰ – 1; | 3D Conformal RT (10); IMRT (10) | Compare the effects of 3D conformal RT with IMRT on swallowing function | FEES and Self-rating of symptoms | No difference between 3D conformal RT and IMRT in the swallowing outcome | 3/5 |
| Fua et al | 28 (7F:21M) | 50.0 | Stage Ⅰ – 1; | Whole-field IMRT (20); IMRT with central shielding (8); Induction chemotherapy (21); Concurrent chemotherapy (23) | Quantify the dose delivered to the pharyngo–esophageal axis usingIMRT techniques and correlate with swallowing toxicity | Clinical assessment; feeding tube placement duration | Central shielding was effective in reducing acute RT toxicity of dysphagia | 4/5 |
| Jiang et al | 134 (33F:101M) | 44 | T1-T2 – 37, | IMRT (134); Neoadjuvant chemotherapy (48); Concurrent chemotherapy (108) | Investigate the dose-volume effect on the swallowing function | Dose-volume histogram and RTOG/EORTC scale score and MDADI | Significant relationship between dysphagia and radiation doses to the superior and inferior constrictor muscles | 4/5 |
| Messer et al | 72 (15F:57M) | 52 ± 12 | T1-T2 – 29, | IMRT (72); Induction chemotherapy (49); Concurrent chemotherapy (63) | Characterize the changes in the MRI signal intensity in dysphagia-associated structures as a function of RT | Signal intensity of MRI | Dose dependent decrease in the late T1 signal intensity is associated with higher RT doses to the superior pharyngeal constrictor muscle | 5/5 |
| Fong et al | 13 (2F:11M) | 42.0 | T1 – 1, | RT (9); C/RT (4) | Determine the use of balloon dilation for treating cricopharyngeal dysfunction | VFSS and MDADI | Balloon dilation was effective in treating dysphagia, reduce aspiration risk and improve quality of life | 4/5 |
| Lei et al | 9 (9M) | 62.5 | Not available | RT only (9) | Study the effect of modified laryngotracheal separation on patients with intractable aspiration pneumonia | Incidence of pneumonia, weight, nutritional status | Modified laryngotracheal separation is effective in eliminating intractable aspiration pneumonia. Careful patient selection is required | 3/5 |
| Lin et al | 20 (8F:12M) | Electrical stim group – 52.3; Exercise group – 56.1 | Stage Ⅱ – 3; | Single RT (17); 2 courses of RT (3) | Assess the effectiveness of functional electrical stimulation on NPC patients | VFSS and QoL measures | Functional electrical stimulation was effective in improving swallowing function and its related quality of life | 4/5 |
| Long & Wu | 60 (31F:29M) | Treatment group – 56.5; Control group – 55.83 | Not available | RT (60) | Evaluate the therapeutic effect of (NMES and balloon dilation in NPC patients | Clinical assessment, VFSS | Combined NMES and balloon dilatation treatment were effective for improving swallowing function | 3/5 |
| Tang et al | 43 (11F:32M) | 49.3 ± 11.0 | Not available | RT only (43) | Evaluate the therapeutic effect of rehabilitation therapy on dysphagia and trismus in NPC patients | Clinical assessment of swallowing and jaw opening | Rehabilitation training can improve swallow function and slow down the progress of trismus in NPC patients | 3/5 |
| Wang et al | 12(3F:9M) | 52.58 ± 10.82 | Not available | RT only (12) | Evaluate the effect of cervical esophagostomy in NPC patients with severe dysphagia | QoL measures, incidence of pneumonia | Cervical esophagostomy can improve the life quality of patients with dysphagia induced by radiotherapy for nasopharyngeal carcinoma | 4/5 |
NPC: nasopharyngeal cancer; MMAT: Mixed Methods Appraisal Tool; IMRT: intensity modulated radiation therapy; RT: radiation therapy; FEES: fiberoptic endoscopic evaluation of swallowing; RTOG: Radiation Therapy Oncology Group; EORTC: European Organization for Research and Treatment of Cancer; MDADI: MD Anderson Dysphagia Inventory; C/RT: chemo-radiation therapy; VFSS: videofluoroscopic swallowing study; QoL: quality of life; NMES: neuromuscular electrical stimulation.
Summary of articles reporting on dysphagia-related quality of life post NPC.
| Author | Sample size (gender) | Age (years, Mean ± SD) | Tumour staging of participants | Treatment techniques ( | Main objectives | Outcome measures | Main findings | MMAT quality rating |
|---|---|---|---|---|---|---|---|---|
| Li et al. | 334 (90F:244M) | 51.07 ± 10.07 | Stage I – 5 | 2D-RT (252), IMRT (82); Neoadjuvant chemotherapy (141); Concurrent chemotherapy (179) | Investigate the swallowing status and its impact on quality of life | VFSS and scores of the WHO quality of life – BREF | Dysphagia as proven by VFSS is negatively correlated to domains of the WHOQOL-BREF | 4/5 |
| Lovell et al. | 51 (11F:40M) | 46.0 ± 10 | Stage I-II – 19, Stage III-IV – 32 | RT only (20), C/RT (31) | Determine the impact of dysphagia on QoL in patients treated for NPC | QoL measurements | Swallowing difficulties negatively impacts quality of life in NPC patients | 5/5 |
| Tong et al. | 60 (18F:42M) | 34–71 | Not available | Not specified | Explore the perceptions and experiences of swallowing difficulties in NPC patients post-RT | Transcribed interviews on QoL | Informants' concerns focused more on the threat of cancer recurrence, thus paid less attention to the radiation-induced swallowing complication | 4/5 |
NPC: nasopharyngeal cancer; MMAT: Mixed Methods Appraisal Tool; RT: radiation therapy; IMRT: intensity modulated radiation therapy; VFSS: videofluoroscopic swallowing study; WHOQOL-BREF: World Health Organization Quality of life - BREF; C/RT: chemo-radiation therapy; QoL: quality of life.
Reported prevalence of swallowing deficits.
| Oral phase | |
| Oral stasis | 27.6%–34.8% |
| 69%–100% | |
| Increased mucosal coating | 32.9%-72.4% |
| 96.5% | |
| Poor bolus formation/transfer | 46%–54% |
| 0–45% | |
| Prolonged oral transit | 76%–96% |
| Pharyngeal phase | |
| Residue at valleculae | 40.8%–78.3% |
| 0–100% | |
| 85.8%–100.0% | |
| Residue at pyriform fossa | 39.5%–82.6% |
| 93.5% | |
| 73% | |
| 0–60% | |
| 54%–100% | |
| Laryngeal penetration | 16.7% |
| 0–15.8% | |
| 47%–62% | |
| 0–68% | |
| 17.6%–37.6% | |
| 22.5% | |
| 10%–35% | |
| 48.7%–91.6% | |
| Aspiration | 0 |
| 0–4% | |
| 83.9% | |
| 17.0%–20.5% | |
| 0–22% | |
| 74% | |
| 33.3% | |
| 9.4%–73.0% | |
| 17.5% | |
| 83.3% | |
| 0–10% | |
| 9.7%–71.8% | |
Data reported for multiple time points, bolus types, or treatment groups are indicated as ranges.
Reported prevalence of functional impairments contributing to swallowing deficits.
| Oral phase | |
| Impaired lingual control | 0–40% |
| Pharyngeal phase | |
| Velopharyngeal incompetence | 27.8% |
| 58.1% | |
| 10% | |
| 23.0%–95.8% | |
| Delay or absence of swallow reflex | 87.1% |
| 36%–62% | |
| 2.6%–52.1% | |
| Decreased pharyngeal contraction | 1.3%–5.7% |
| 80.6% | |
| 78%–92% | |
| 69% | |
| 1.8%–71.8% | |
| Incomplete hyoid bone elevation | 8.7%–15.8% |
| 94% | |
| 1.8%–23.9% | |
| Impaired laryngopharyngeal sensation | 88% |
| Esophageal phase | |
| Cervical esophageal clearance problem | 82.8%–97.0% |
Data reported for multiple time points, bolus types, or treatment groups are indicated as range.